期刊文献+

外周血CD34^+细胞数在有危险因素的急性心肌梗死患者中的变化 被引量:1

Change of CD34^+ progenitor cells number in peripheral blood of acute myocardial infarction patients with cardiovascular risk factors
暂未订购
导出
摘要 目的:健康人外周血中前体CD34+细胞数目很少,但在急性缺血时,这些细胞可以从骨髓动员到外周血。研究发现,有心血管危险因素的患者,外周血CD34+细胞数目是减少的。然而,有心血管事件危险因素的患者,急性心肌梗死是否能促进CD34+细胞的动员,目前尚不完全清楚。方法:42例心血管事件危险因素患者被分成两组:急性心肌梗死组20例,无冠状动脉粥样硬化性心脏病组22例。同时,没有冠心病及任何心血管病危险因素的16例自愿者入选为健康对照组。流式细胞仪分析外周血CD34+细胞数目。结果:急性心肌梗死组,外周血CD34+细胞的数目为(1.915±0.667)/μl,与健康对照组(1.925±0.629)/μl值比较,P=0.963。无冠状动脉粥样硬化性心脏病组,外周血CD34+细胞的数目为(1.804±0.605)/μl。在心肌梗死组与无冠心病组间比较,外周血CD34+细胞的数目无明显不同(P=0.575)。而且,患者并存心血管危险因素的多少与外周血中CD34+细胞水平似乎成反向相关。结论:有心血管事件危险因素患者,发生急性心肌梗死后外周血前体CD34+细胞未发现增加。由此提示心血管病危险因素可能抑制急性缺血诱导的前体CD34+细胞的动员,且与危险因素多少相关。 AIM: Evidence demonstrates that the circulating CD34^+ progenitor cells in healthy people are very few; however, they can be mobilized into peripheral blood from bone marrow ( BM ) in response to acute myocardial ischemic events and contribute to regeneration of myocardial tissues. Studies have shown that various cardiovascular risk factors can influence mobilization of CD34^+ cells. This study was conducted to investigate the change in circulating CD34^+ cells of patients with cardiovascular risk factors during acute myocardial infarction (AMI). METHODS: 42 patients with cardiovascular risk factors were classifted into 2 groups: patients with acute myocardial infarction ( n = 20 ) and patients without coronary artery disease ( n = 22). 16 volunteers without any evidence of cardiovascular risk factors and coronary artery diseases were chosen as healthy controls. The number of CD34^+ cells in peripheral blood ( PB) was analyzed by flow cytometer. RESULTS :The number of circulating CD34^+ cells was ( 1. 915 ± 0. 667 )/μl in AMI patients as against ( 1. 925 ± 0. 629 )/μl in healthy controls ( P = 0. 963 ) and ( 1. 804± 0. 605 )/μl in patients without CAD. There was no significant difference between patients with AMI and patients without CAD ( P = 0.575 ). Moreover, an inverse correlation between circulating CD34^+ progenitor cells and the number of risk factors was detected. CONCLUSION: Circulating CD34^+ progenitor cells do not increase in AMI patients with cardiovascular risk factors. It is suggested that acute-ischemia-induced mobilization of CD34^+ precursor cells may be inhibited by cardiovascular risk factors, which iscorrelated with the number of risk factors.
出处 《心脏杂志》 CAS 2005年第4期367-370,共4页 Chinese Heart Journal
基金 国家自然科学基金资助项目 批准号:3037059
关键词 心血管危险因素 心肌梗塞 急性 CD34^+前体细胞 cardiovascular risk factors myocardial infarction, acute CD34^+ progenitor ceils
  • 相关文献

参考文献13

  • 1Tiwari A, Hmilton G, Seifalian AM, et al. Regarding "isolation of endothelial cells and their progenitor cells from human peripheral blood" [ J ]. J Vasc Surg, 2002, 35 : 827.
  • 2Hristov M, Erl W, Weber PC. Endothelial progenitor cells mobilization, differenfion ,and homing[ J]. Arterioscler Thromb Vasc Biol,2003, 23:1185-1189.
  • 3Orilic D. Adult bone marrow stem cells regenerate myocardium in ischemic heart disease[J]. Ann N YAcad Sci, 2003, 996:152 -157.
  • 4Asahara T, Kalka C, Masuda H, et al. Ischemia- and cytokine.induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularizarion[ J]. Nat Med, 1999, 5:434 -438.
  • 5Mutin M, Canary I, Blann CA, et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells [ J ]. Blood, 1999, 93 ( 9 ) :2951 - 2958.
  • 6Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with myocardial infarction[ J]. Circulation, 2001, 103 : 2776 -2779.
  • 7Rafii SH, Meeus S, Dias S, et ad. Contribution of marrow-derived progenitors to vascular and cardiac regeneration [ J ]. Dev Biol,2002, 13:61-67.
  • 8Masuda H, Kalka C , Takahashi T, et al. The effect of progesterone on endothelial progenitor cell kinetics for physiological neovascularization of uterus [ J]. Circulation, 1999, 100 ( suppl I) : I691 -I692. (Abstract).
  • 9Masuda H, Kalka C, Takahashi T,et al. Regulatory role of estrogen on endothelial progenitor cell kinetics for cyclic endothmetrial neovascularization [ J ]. Circulation, 1999, 100 ( suppl I) : I475. ( Abstract).
  • 10北京市临床流式细胞分析协作组.流式细胞术三色分析调查成年人外周血CD34^+造血干细胞绝对计数参考范围[J].中华检验医学杂志,2002,25(1):58-60. 被引量:15

二级参考文献12

  • 1Rizzo D. New summary slides show current trends in BMT. ABMTR Newsletter 1998; 5(1):4-10.
  • 2To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses & 127 of blood stem cells. Blood 1997;89:2233-2258
  • 3Sutherlan DR, Anderson L. The ISHAGE Guidelines for CD34+ cell determination by flow cytometry. J hematotherapy 1996;5:213-226
  • 4Johnsen HE. Report from a Nordic Workshop on CD34+ cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J hematotherapy 1995;4:21-28
  • 5Johnsen HE, Nordic. Flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from Second Nordic Workshop. J hematotherapy 1996;5:237-245
  • 6Brecher ME, Sims L, Schmitz J, et al. North American multicenter study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J hematotherapy 1996;5:227-236 .
  • 7Lowdell MW, Bainbrige DR. External quality assurance for CD34+ cell enumeration result for a preliminary national trail: Bone Marrow Transplantation 1996;17:849-853
  • 8Gross HJ, Verwer BJH, Houck D, et al. Detection of rare cell at a frequency of one per million by flow cytometry. Cytometry 1993;14:519-526
  • 9McCarthy RC, Fetterhoff TJ. Issues for quality assurance in clinical flow cytometry. Arch Pathol Lab Med 1989;113:658-666
  • 10Loken MR, Owens Ma. Flow cytometry principles for clinical Laboratory practice, quality assurance for quantitative immunophenotyping, Wiley-Liss, New york. 1995:11-13

共引文献14

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部